Laying the Groundwork to Confront the Final Frontier of CNS Metastasis in NSCLC with Targetable Driver Mutations
The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer
Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules
Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers
Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE)
First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study
First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France
Survival after Sublobar Resection for Early-Stage Lung Cancer: Methodological Obstacles in Comparing the Efficacy to Lobectomy
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the Trial Registry
HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Incidence of Brain Metastasis at the Initial Diagnosis of Lung Squamous Cell Carcinoma on the Basis of Stage, Excluding Brain Metastasis
Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma
Germline and Somatic DICER1 Mutations in a Well-Differentiated Fetal Adenocarcinoma of the Lung
Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle
How Can We Use the Multimodality Prognostic Score?
Clinical Relevance of Our Multimodality Prognostic Score
Cryotherapy for Lung Metastases: A Procedure That Deserves Evaluation in a Randomized Trial
Proposals for the M-descriptors of the Eight TNM Classification for Non–Small Cell Lung Cancer
Reply to the Letter to the Editor by Hendriks et al.